Clinical Trial: Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086755) titled 'Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury' on July 18.

Brief Summary: The objective of this study is to assess the efficacy and safety of vadadustat for treating hospitalized patients with nonintubated Acute Respiratory Distress Syndrome (ARDS) secondary to pathogen-associated lung injury.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Nonintubated Acute Respiratory Distress Syndrome (ARDS) Pathogen-associated Lung Injury

Intervention: DRUG: Vadadustat 900mg

Participants will receive 900mg vadadustat (as oral tablets) for 14 days or...